Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/safety-of-biologics-therapy/descriptif_3849833
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3849833

Safety of Biologics Therapy, Softcover reprint of the original 1st ed. 2016 Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins

Langue : Anglais

Auteur :

Couverture de l’ouvrage Safety of Biologics Therapy

This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters.  It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.


1: Approved Biologics Used For Therapy and their Adverse Effects
2: Monoclonal Antibodies: Introduction
3: Monoclonal Antibodies Approved for Cancer Therapy
4: Other Approved Therapeutic Monoclonal Antibodies 
5: Cytokines
6: Fusion Proteins
7: Peptide Hormones
8: Glycoprotein Hormones
9: Enzymes Approved for Therapy
10: Blood Coagulation 
11: Vaccines
12: Botulinum Neurotoxins
13: Biosimilars

Brian A. Baldo (Retired)
AUA(Pharmacy); BSc(Hons); PhD
Formerly: 
Royal North Shore Hospital of Sydney
Head, Molecular Immunology Unit
Kolling Institute of Medical Research and 
University of Sydney
Sydney, NSW 
AUSTRALIA

The only book available that covers in a single volume the full range of issues surrounding safety of approved biologic therapies

In addition to presenting a detailed examination of adverse effects and safety

The book covers mechanisms of action, Indications for therapy, and immunogenicity of the many and diverse biologic therapeutic agents

Written to be definitive and comprehensive

Relevant to clinicians in all medical disciplines, nurses, pharmacists, biomedical scientists, as well as students in these health care disciplines

Date de parution :

Ouvrage de 610 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 168,79 €

Ajouter au panier

Date de parution :

Ouvrage de 610 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

121,31 €

Ajouter au panier

Ces ouvrages sont susceptibles de vous intéresser